oral semaglutide cardiovascular outcomes soul trial results 2024 2025 and in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the Randomized Cardiovascular outcomes of semaglutide and

We should note that semaglutide hasnt been studied in people with a history of pancreatitis

So far, bariatric surgery has proven to be the most effective approach to body weight (BW) reduction, as a recent network meta-analysis demonstrated that it was associated with a 17.7% greater BW loss compared to lifestyle intervention/medical therapy 6 , with substantial improvements or remission of T2D, dyslipidemia and hypertension 7

Plasma total homocysteine in healthy subjects: Sex-specific relation with biological traits

By treating obesity as a chronic disease and improving underlying metabolic function, these treatments offer a range of significant, clinically proven health advantages

These characteristics support its use in ameliorating obesity-related gastrointestinal dysfunction, helping patients establish regular eating patterns, reducing gastrointestinal irritation from overeating, and alleviating postprandial discomfort such as bloating and indigestion